[go: up one dir, main page]

WO2008081934A1 - Agent for facilitating the development of brain in infant comprising milk-derived phospholipid and food composition comprising the same - Google Patents

Agent for facilitating the development of brain in infant comprising milk-derived phospholipid and food composition comprising the same Download PDF

Info

Publication number
WO2008081934A1
WO2008081934A1 PCT/JP2007/075288 JP2007075288W WO2008081934A1 WO 2008081934 A1 WO2008081934 A1 WO 2008081934A1 JP 2007075288 W JP2007075288 W JP 2007075288W WO 2008081934 A1 WO2008081934 A1 WO 2008081934A1
Authority
WO
WIPO (PCT)
Prior art keywords
agent
infant
milk
brain
facilitating
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/JP2007/075288
Other languages
French (fr)
Japanese (ja)
Inventor
Toshiaki Shimizu
Kyoko Tanaka
Takahiro Kanno
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Meiji Dairies Corp
Juntendo Educational Foundation
Original Assignee
Meiji Dairies Corp
Juntendo Educational Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Meiji Dairies Corp, Juntendo Educational Foundation filed Critical Meiji Dairies Corp
Priority to JP2008552185A priority Critical patent/JP5959137B2/en
Priority to CN2007800518292A priority patent/CN101636167B/en
Priority to HK10106916.6A priority patent/HK1140427B/en
Publication of WO2008081934A1 publication Critical patent/WO2008081934A1/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A23L33/12—Fatty acids or derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A61K31/688—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols both hydroxy compounds having nitrogen atoms, e.g. sphingomyelins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/20—Milk; Whey; Colostrum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Food Science & Technology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Hospice & Palliative Care (AREA)
  • Nutrition Science (AREA)
  • Mycology (AREA)
  • Psychiatry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Polymers & Plastics (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Zoology (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Dairy Products (AREA)

Abstract

Disclosed is an agent for facilitating the development of the brain in an infant, which comprises an effective amount of a milk-derived phospholipid or a sphingomyelin. Also disclosed is a food composition for improving the nervimotion and/or the learning function in an infant, which comprises the agent. For direct intake, the agent preferably comprises at least 0.027 wt% of a milk-derived phospholipid or at least 0.005 wt% of a sphingomyelin.
PCT/JP2007/075288 2006-12-28 2007-12-28 Agent for facilitating the development of brain in infant comprising milk-derived phospholipid and food composition comprising the same Ceased WO2008081934A1 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
JP2008552185A JP5959137B2 (en) 2006-12-28 2007-12-28 Infant brain development promoter containing milk-derived phospholipid and food composition containing the same
CN2007800518292A CN101636167B (en) 2006-12-28 2007-12-28 Infant brain development promoter containing milk-derived phospholipid and food composition containing the same
HK10106916.6A HK1140427B (en) 2006-12-28 2007-12-28 Agent for facilitating the development of brain in infant comprising milk-derived phospholipid and food composition comprising the same

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2006354897 2006-12-28
JP2006-354897 2006-12-28

Publications (1)

Publication Number Publication Date
WO2008081934A1 true WO2008081934A1 (en) 2008-07-10

Family

ID=39588614

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2007/075288 Ceased WO2008081934A1 (en) 2006-12-28 2007-12-28 Agent for facilitating the development of brain in infant comprising milk-derived phospholipid and food composition comprising the same

Country Status (4)

Country Link
JP (1) JP5959137B2 (en)
KR (1) KR20090097945A (en)
CN (1) CN101636167B (en)
WO (1) WO2008081934A1 (en)

Cited By (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010146831A1 (en) * 2009-06-16 2010-12-23 Meiji Dairies Corporation Prenatal milk-derived composition for preventing the risk of low birthweight of newborns
WO2011096413A1 (en) * 2010-02-03 2011-08-11 花王株式会社 Agent for improving motility function
WO2011115491A1 (en) 2010-03-17 2011-09-22 N.V. Nutricia Infant nutrition for improving fatty acid composition of brain membranes
US8883219B2 (en) 2008-12-11 2014-11-11 N. V. Nutricia Nutritional compositions with coated lipid globules
US9320294B2 (en) 2008-09-02 2016-04-26 N.V. Nutricia Nutritional compositions with lipid globules with a core comprising vegetable lipids and a coating comprising phospholipids or polar lipids
WO2017179602A1 (en) * 2016-04-13 2017-10-19 株式会社明治 Brain function-improving composition for newborns
CN114145347A (en) * 2021-11-30 2022-03-08 内蒙古伊利实业集团股份有限公司 Phospholipid composition capable of improving learning and memory ability and application thereof
US11376222B2 (en) 2013-11-01 2022-07-05 N.V. Nutricia Lipid composition for improving body composition during catch-up growth
US11389403B2 (en) 2015-10-15 2022-07-19 N.V. Nutricia Infant formula with special lipid architecture for promoting healthy growth
US11632974B2 (en) 2016-12-09 2023-04-25 N.V. Nutricia Nutritional composition for improving cell membranes
EP4233904A2 (en) * 2015-12-14 2023-08-30 Société des Produits Nestlé S.A. Compositions and their use

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE536599C3 (en) * 2012-04-10 2017-01-10 Hero Ag Nutritional composition with low calorie and low protein content
EP3389406A1 (en) * 2015-12-14 2018-10-24 Nestec S.A. Nutritional compositions and infant formulas to promote myelination in the brain
CN112042750B (en) * 2020-09-09 2022-04-05 北京三元食品股份有限公司 A kind of infant formula milk powder rich in milk fat globule membrane protein, phospholipids and oligosaccharides and preparation method thereof
CN114711295A (en) * 2022-04-29 2022-07-08 安徽东荣堂生物科技有限公司 Complementary food nutrition supplement food
CN117652577A (en) * 2023-12-12 2024-03-08 内蒙古伊利实业集团股份有限公司 Infant formula milk powder capable of affecting brain hippocampus protein expression and preparation method thereof

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2001128642A (en) * 1999-11-02 2001-05-15 Meiji Milk Prod Co Ltd A food composition containing a milk-derived phospholipid.
JP2003252765A (en) * 2002-02-28 2003-09-10 Snow Brand Milk Prod Co Ltd Agent for treatment of intestinal movement insufficiency
WO2008005033A1 (en) * 2006-06-30 2008-01-10 Abbott Laboratories Infant formulas for early brain development

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH01279827A (en) * 1988-05-02 1989-11-10 Taiyo Fishery Co Ltd Brain function improving composition, learning ability enhancer, memory enhancer, dementia preventive agent, dementia treatment agent, or functional food having a brain function improving effect
JP4568464B2 (en) * 2001-11-07 2010-10-27 雪印乳業株式会社 Memory disorder prevention and treatment
JP4535662B2 (en) * 2002-04-10 2010-09-01 太陽化学株式会社 Brain function improving composition
AU2006251569B2 (en) * 2005-05-23 2012-06-21 Massachusetts Institute Of Technology Compostions containing pufa and/or uridine and methods of use thereof
JP2007246404A (en) * 2006-03-14 2007-09-27 Snow Brand Milk Prod Co Ltd Learning ability-improving agent

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2001128642A (en) * 1999-11-02 2001-05-15 Meiji Milk Prod Co Ltd A food composition containing a milk-derived phospholipid.
JP2003252765A (en) * 2002-02-28 2003-09-10 Snow Brand Milk Prod Co Ltd Agent for treatment of intestinal movement insufficiency
WO2008005033A1 (en) * 2006-06-30 2008-01-10 Abbott Laboratories Infant formulas for early brain development

Cited By (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9345259B2 (en) 2008-09-02 2016-05-24 N.V. Nutricia Nutritional compositions with coated lipid globules
US9707240B2 (en) 2008-09-02 2017-07-18 N.V. Nutricia Nutritional compositions with lipid globules with a core comprising vegetable lipids and a coating comprising phospholipids or polar lipids
US9700568B2 (en) 2008-09-02 2017-07-11 N.V. Nutricia Nutritional compositions with coated lipid globules
US9320294B2 (en) 2008-09-02 2016-04-26 N.V. Nutricia Nutritional compositions with lipid globules with a core comprising vegetable lipids and a coating comprising phospholipids or polar lipids
US8883219B2 (en) 2008-12-11 2014-11-11 N. V. Nutricia Nutritional compositions with coated lipid globules
WO2010146831A1 (en) * 2009-06-16 2010-12-23 Meiji Dairies Corporation Prenatal milk-derived composition for preventing the risk of low birthweight of newborns
CN102802442A (en) * 2009-06-16 2012-11-28 株式会社明治 Prenatal milk-derived composition for preventing the risk of low birthweight of newborns
CN102802442B (en) * 2009-06-16 2014-05-07 株式会社明治 Prenatal milk-derived composition for preventing the risk of low birthweight of newborns
WO2011096413A1 (en) * 2010-02-03 2011-08-11 花王株式会社 Agent for improving motility function
US9474764B2 (en) 2010-03-17 2016-10-25 N.V. Nutricia Infant nutrition for improving fatty acid composition of brain membranes
WO2011115476A1 (en) 2010-03-17 2011-09-22 N.V. Nutricia Infant nutrition for improving fatty acid composition of brain membranes later in life
WO2011115490A1 (en) 2010-03-17 2011-09-22 N.V. Nutricia Infant nutrition for improving fatty acid composition of brain membranes
WO2011115491A1 (en) 2010-03-17 2011-09-22 N.V. Nutricia Infant nutrition for improving fatty acid composition of brain membranes
US10548869B2 (en) 2010-03-17 2020-02-04 N.V. Nutricia Infant nutrition for improving fatty acid composition of brain membranes
US11376222B2 (en) 2013-11-01 2022-07-05 N.V. Nutricia Lipid composition for improving body composition during catch-up growth
US11389403B2 (en) 2015-10-15 2022-07-19 N.V. Nutricia Infant formula with special lipid architecture for promoting healthy growth
EP4233904A2 (en) * 2015-12-14 2023-08-30 Société des Produits Nestlé S.A. Compositions and their use
WO2017179602A1 (en) * 2016-04-13 2017-10-19 株式会社明治 Brain function-improving composition for newborns
US10925906B2 (en) 2016-04-13 2021-02-23 Meiji Co., Ltd. Composition for improving brain function for neonates
US11632974B2 (en) 2016-12-09 2023-04-25 N.V. Nutricia Nutritional composition for improving cell membranes
CN114145347A (en) * 2021-11-30 2022-03-08 内蒙古伊利实业集团股份有限公司 Phospholipid composition capable of improving learning and memory ability and application thereof

Also Published As

Publication number Publication date
CN101636167A (en) 2010-01-27
JP5959137B2 (en) 2016-08-02
JPWO2008081934A1 (en) 2010-04-30
CN101636167B (en) 2012-10-03
KR20090097945A (en) 2009-09-16
HK1140427A1 (en) 2010-10-15

Similar Documents

Publication Publication Date Title
WO2008081934A1 (en) Agent for facilitating the development of brain in infant comprising milk-derived phospholipid and food composition comprising the same
WO2008054208A3 (en) Use of nutritional compositions for preventing disorders
WO2007073192A3 (en) Infant nutritional compositions for preventing obesity
WO2006138669A3 (en) Life-like anatomic feature for testing injection of soft tissue fillers
PL1887888T3 (en) Use of polydextrose for simulating the functional attributes of human milk oligosaccharides in formula-fed infants
SI1921924T1 (en) Low-fat confectionery product being a water-in-oil emulsion
WO2007022344A3 (en) Methods and compositions for the preventioin and treatment of kidney disease
PT1901620T (en) Phosphatidylserine enriched milk fractions for the formulation of functional foods
WO2008013984A3 (en) Compositions and methods for treating or preventing ophthalmic disease
WO2007081878A3 (en) Indoleamine 2,3-dioxygenase pathways in the generation of regulatory t cells
WO2005051092A3 (en) Method of decreasing fat deposits and body weight in mammals and birds
WO2007005672A3 (en) Treatment and prevention of respiratory diseases and conditions
WO2007057873A3 (en) Novel compositions to improve gut health and animal performance and methods of making the same
WO2004089964A8 (en) Lipid-regulating agent and use thereof
WO2006056696A3 (en) 2-alcoxy-3,4,5-trihydroxy-alkylamides, preparation thereof, compositions containing them and use thereof
WO2005072704A3 (en) Method of treating acute rhinosinusitis
WO2007003264A3 (en) Polyaspartic acid derivatives in covering agents containing polysiloxane
WO2008050133A3 (en) Inhibition of beta-amyloid aggregation
WO2008036733A3 (en) Methods for treatment of vesicle transport disorders
WO2007079312A3 (en) Compositions and methods for treating actin-mediated medical conditions
WO2008075333A3 (en) Edible compositions for preventing hair loss
WO2006087629A3 (en) Rapidly disintegrating composition of olanzapine
WO2008035370A3 (en) Compositions for prevention and treatment of mastitis and metritis
CA2534483A1 (en) Composition and method for treating bezoar and trichobezoar
WO2007014347A3 (en) Method of treating a condition associated with phosphorylation of task-1

Legal Events

Date Code Title Description
WWE Wipo information: entry into national phase

Ref document number: 200780051829.2

Country of ref document: CN

121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 07860491

Country of ref document: EP

Kind code of ref document: A1

WWE Wipo information: entry into national phase

Ref document number: 2008552185

Country of ref document: JP

NENP Non-entry into the national phase

Ref country code: DE

WWE Wipo information: entry into national phase

Ref document number: 1020097015502

Country of ref document: KR

122 Ep: pct application non-entry in european phase

Ref document number: 07860491

Country of ref document: EP

Kind code of ref document: A1